Sibel Health Launches FDA-Cleared ANNE® Maternal for Wireless Maternal-Fetal Monitoring

A Game-Changer in Maternal-Fetal Monitoring

Sibel Health has recently garnered FDA 510(k) clearance for the ANNE® Maternal, a transformative wireless platform in maternal-fetal monitoring. This groundbreaking device is lauded as the first of its kind because it enables continuous and simultaneous monitoring of both maternal and fetal health without the encumbrance of traditional wired systems. ANNE® Maternal integrates cutting-edge wearable sensor technology with robust clinical decision support, representing a significant advancement towards establishing continuous maternal monitoring as the standard of care across the globe.

The Need for Innovation in Maternal Health

With maternal mortality rates in the U.S. being alarmingly high at 22 deaths per 100,000 live births, Sibel Health's innovations come at a critical time. The March of Dimes has graded U.S. maternal and infant health as a D+, highlighting the urgent need for improvements in the system. By enabling continuous monitoring, ANNE® Maternal aims to revolutionize labor and delivery practices, offering a solution to improve the safety and well-being of mothers and their babies during crucial health moments post-delivery.

Features of the ANNE® Maternal Platform

Utilizing soft, flexible epidermal sensors, the ANNE® Maternal platform provides seamless tracking of essential maternal vital signs, such as:

- Heart Rate
- Respiratory Rate
- Blood Oxygen Saturation
- Skin Temperature

Moreover, it includes features for monitoring fetal heart rates and uterine contractions. Unlike traditional systems that restrict patients to bedridden positions due to cumbersome wired equipment, ANNE® Maternal allows mothers the freedom to move comfortably while still receiving comprehensive care.

The system supports real-time analytics with bedside and central monitoring capabilities, supplemented by an integrated electronic Modified Early Obstetric Warning System (MEOWS). This innovative alert system ensures that clinicians receive automated signals for prompt evaluations, potentially lowering risks during labor and delivery.

Global Impact and Accessibility

The journey toward the realization of ANNE® Maternal has been fortified by a $17.5 million grant from the Gates Foundation, aimed at facilitating the adoption of continuous monitoring solutions across low- and middle-income countries (LMICs). This grant is a hallmark achievement for Sibel Health, originating from Northwestern University, and signifies a full-circle moment in their ambition to make impactful healthcare accessible to all.

Dr. Steve Xu, CEO and Co-Founder of Sibel Health, emphasizes the unique dual focus of the platform: combining stringent clinical validation required by the FDA with designs specifically aimed at deployment in resource-limited environments. This dual approach helps bridge the gap between innovation in developed markets and the critical health challenges faced by mothers in low-resource settings.

Collaborative Research and Implementation

Currently, ANNE® Maternal has been deployed in several nations, including India, Pakistan, Nigeria, and Rwanda, in collaboration with the University of Edinburgh and other esteemed research institutions. This initiative underscores the need to actively monitor women's conditions during labor to preemptively address and prevent risks associated with childbirth.

Dr. Rosemary Townsend, a senior lecturer in Obstetrics at the University of Edinburgh, highlights the essence of this technology, stressing the need for comfort and thorough monitoring to improve maternal outcomes.

Further investments are planned, including a $5 million grant aimed at developing AI-powered features within the ANNE® Maternal system, designed for low-resource settings. By leveraging Sibel Health’s existing infrastructure, future updates promise to enhance both functionality and accessibility.

Conclusion

The FDA clearance of ANNE® Maternal opens doors to a new era for maternal-fetal health. As healthcare systems worldwide strive to improve maternal care standards, platforms like ANNE® Maternal are not just revolutionary but essential. Sibel Health is turning a critical spotlight on maternal health, ensuring that neither mothers nor their children have to face preventable complications during one of the most vulnerable times in their lives.